\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ was\\ a\\ 9kg\\ male\\ whose\\ exam\\ was\\ significant\\ for\\ \\+\\ inspiratory\\ stridor\\ and\\ retrognathia\\.\\ \\ lab\\ findings\\ included\\ a\\ negative\\ strep\\ throat\\ culture\\ and\\ a\\ cbc\\ with\\ 18\\.5\\ wbc\\ \\(26\\%\\ monocytes\\,\\ 12\\%\\ myelocytes\\)\\,\\ rbc\\ 3\\.1\\,\\ hgb\\ 8\\.4\\,\\ hct\\ 25\\.4\\,\\ and\\ fibrinogen\\ 64\\.1\ \(0\)\
\-\ antibiotics\\ and\\ chemotherapy\ \(0\)\
\-\ thickening\\ \\ of\\ \\ the\\ \\ epiglottis\\,\\ \\ aryepiglottic\\ \\ folds\\ \\ and\\ \\ prevertebral\\ soft\\ \\ tissues\ \(0\)\
\-\ epiglottitis\\ secondary\\ to\\ aml\\-\\ m5\ \(0\)\
\-\ \\â\\€\\¢\\	epiglottitis\ \(0\)\
\-\ \\â\\€\\¢\\	croup\ \(0\)\
\-\ \\â\\€\\¢\\	bronchiolitis\ \(0\)\
\-\ \\â\\€\\¢\\	bacterial\\ tracheitis\ \(0\)\
\-\ \\â\\€\\¢\\	uvulitis\ \(0\)\
\-\ \\â\\€\\¢\\	foreign\\ body\ \(0\)\
\-\ \\â\\€\\¢\\	peritonsillar\\ or\\ retropharyngeal\\ abscess\ \(0\)\
\-\ an\\ 8\\ month\\ old\\ male\\ presented\\ to\\ the\\ ed\\ with\\ a\\ 2\\ week\\ history\\ of\\ fever\\,\\ cough\\,\\ increased\\ hoarseness\\,\\ increased\\ work\\ of\\ breathing\\,\\ and\\ decreased\\ po\\ intake\\.\\ the\\ patient\\ was\\ taking\\ amoxicillin\\ for\\ otitis\\ media\\,\\ \\ without\\ an\\ improvement\\ of\\ his\\ symptoms\\.\ \(0\)\
\-\ epiglottitis\\ is\\ not\\ commonly\\ seen\\ since\\ the\\ advent\\ of\\ the\\ haemophilus\\ influenza\\ vaccine\\.\\ \\ however\\,\\ this\\ patient\\ was\\ susceptible\\ to\\ the\\ disease\\ secondary\\ to\\ being\\ immunocompromised\\ because\\ of\\ his\\ aml\\.\\ \\ once\\ his\\ aml\\ was\\ identified\\ and\\ treated\\,\\ the\\ patient\\ had\\ a\\ good\\ recovery\\ and\\ prognosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ epiglottitis\\:\\ 0\\.11855144781138202\ \(0\)\
\-\ aml\\:\\ 0\\.063033475170961\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.058346279048783055\ \(0\)\
\-\ 9kg\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ retrognathia\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ myelocytes\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ 64\\.1\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ aml\\-\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ uvulitis\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ advent\\:\\ 0\\.04689105544663031\ \(0\)\
\-\ 25\\.4\\:\\ 0\\.04320410235854549\ \(0\)\
\-\ m5\\:\\ 0\\.04320410235854549\ \(0\)\
\-\ tracheitis\\:\\ 0\\.04320410235854549\ \(0\)\
\-\ 18\\.5\\:\\ 0\\.04104737306009781\ \(0\)\
\-\ his\\:\\ 0\\.0393014206539404\ \(0\)\
\-\ monocytes\\:\\ 0\\.03833021548687446\ \(0\)\
\-\ aryepiglottic\\:\\ 0\\.03833021548687446\ \(0\)\
\-\ haemophilus\\:\\ 0\\.03833021548687446\ \(0\)\
\-\ fibrinogen\\:\\ 0\\.037360419972013\ \(0\)\
\-\ bronchiolitis\\:\\ 0\\.037360419972013\ \(0\)\
\-\ croup\\:\\ 0\\.036540469547399916\ \(0\)\
\-\ peritonsillar\\:\\ 0\\.036540469547399916\ \(0\)\
\-\ amoxicillin\\:\\ 0\\.036540469547399916\ \(0\)\
\-\ vaccine\\:\\ 0\\.03583019618237586\ \(0\)\
\-\ epiglottis\\:\\ 0\\.03464326239878964\ \(0\)\
\-\ influenza\\:\\ 0\\.03464326239878964\ \(0\)\
\-\ inspiratory\\:\\ 0\\.0332477078005583\ \(0\)\
\-\ 8\\.4\\:\\ 0\\.0332477078005583\ \(0\)\
\-\ susceptible\\:\\ 0\\.0332477078005583\ \(0\)\
\-\ strep\\:\\ 0\\.032853516459315106\ \(0\)\
\-\ retropharyngeal\\:\\ 0\\.032853516459315106\ \(0\)\
\-\ whose\\:\\ 0\\.032486533100341955\ \(0\)\
\-\ immunocompromised\\:\\ 0\\.032486533100341955\ \(0\)\
\-\ 3\\.1\\:\\ 0\\.03069678716086742\ \(0\)\
\-\ stridor\\:\\ 0\\.03044934026919246\ \(0\)\
\-\ hoarseness\\:\\ 0\\.03044934026919246\ \(0\)\
\-\ prevertebral\\:\\ 0\\.030212894723602918\ \(0\)\
\-\ otitis\\:\\ 0\\.029769375527118603\ \(0\)\
\-\ media\\:\\ 0\\.02897990741478736\ \(0\)\
\-\ intake\\:\\ 0\\.027979629587644064\ \(0\)\
\-\ folds\\:\\ 0\\.027542192894894214\ \(0\)\
\-\ was\\:\\ 0\\.02628397665461933\ \(0\)\
\-\ rbc\\:\\ 0\\.02618988364816953\ \(0\)\
\-\ throat\\:\\ 0\\.025977089315117937\ \(0\)\
\-\ po\\:\\ 0\\.025977089315117937\ \(0\)\
\-\ secondary\\:\\ 0\\.025415212409668164\ \(0\)\
\-\ hgb\\:\\ 0\\.02529295432670255\ \(0\)\
\-\ recovery\\:\\ 0\\.024769336918121415\ \(0\)\
\-\ hct\\:\\ 0\\.02468686784080245\ \(0\)\
\-\ breathing\\:\\ 0\\.024446865525480803\ \(0\)\
\-\ culture\\:\\ 0\\.024217226313431824\ \(0\)\
\-\ taking\\:\\ 0\\.024142831409310866\ \(0\)\
\-\ \\+\\:\\ 0\\.023451059450543855\ \(0\)\
\-\ bacterial\\:\\ 0\\.02325993174189458\ \(0\)\
\-\ once\\:\\ 0\\.02325993174189458\ \(0\)\
\-\ foreign\\:\\ 0\\.02239546935094897\ \(0\)\
\-\ increased\\:\\ 0\\.022239199806379315\ \(0\)\
\-\ lab\\:\\ 0\\.022238241679451397\ \(0\)\
\-\ prognosis\\:\\ 0\\.02156034302749331\ \(0\)\
\-\ work\\:\\ 0\\.021294330152096173\ \(0\)\
\-\ improvement\\:\\ 0\\.02120853556736275\ \(0\)\
\-\ \\%\\:\\ 0\\.02120554290793625\ \(0\)\
\-\ 26\\:\\ 0\\.021040989465983116\ \(0\)\
\-\ included\\:\\ 0\\.020959154791305036\ \(0\)\
\-\ cbc\\:\\ 0\\.020310139096821188\ \(0\)\
\-\ good\\:\\ 0\\.01944927194017005\ \(0\)\
\-\ ed\\:\\ 0\\.019210168813243098\ \(0\)\
\-\ \\,\\:\\ 0\\.018719313041089022\ \(0\)\
\-\ tissues\\:\\ 0\\.018655588971091985\ \(0\)\
\-\ 12\\:\\ 0\\.018603183138948307\ \(0\)\
\-\ patient\\:\\ 0\\.018225360232263572\ \(0\)\
\-\ cough\\:\\ 0\\.017416249355362085\ \(0\)\
\-\ commonly\\:\\ 0\\.017151762997104476\ \(0\)\
\-\ antibiotics\\:\\ 0\\.017072959349311176\ \(0\)\
\-\ 8\\:\\ 0\\.016995306160900787\ \(0\)\
\-\ since\\:\\ 0\\.01669555649839477\ \(0\)\
\-\ wbc\\:\\ 0\\.016569547077530913\ \(0\)\
\-\ male\\:\\ 0\\.01643835678603695\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01629226481457907\ \(0\)\
\-\ identified\\:\\ 0\\.016241845963757027\ \(0\)\
\-\ because\\:\\ 0\\.015901693173330043\ \(0\)\
\-\ being\\:\\ 0\\.01583929774893914\ \(0\)\
\-\ week\\:\\ 0\\.01543625222515015\ \(0\)\
\-\ thickening\\:\\ 0\\.015407577498368892\ \(0\)\
\-\ fever\\:\\ 0\\.015379056524212585\ \(0\)\
\-\ body\\:\\ 0\\.014762041024941937\ \(0\)\
\-\ abscess\\:\\ 0\\.01437146938369291\ \(0\)\
\-\ month\\:\\ 0\\.01363624755745005\ \(0\)\
\-\ treated\\:\\ 0\\.013605589553637549\ \(0\)\
\-\ negative\\:\\ 0\\.013575107241355714\ \(0\)\
\-\ decreased\\:\\ 0\\.013514661716619997\ \(0\)\
\-\ however\\:\\ 0\\.012656213061686544\ \(0\)\
\-\ an\\:\\ 0\\.01257090281153968\ \(0\)\
\-\ presented\\:\\ 0\\.01239020018628941\ \(0\)\
\-\ significant\\:\\ 0\\.012222591229011827\ \(0\)\
\-\ symptoms\\:\\ 0\\.011327965302649675\ \(0\)\
\-\ soft\\:\\ 0\\.011068759382944415\ \(0\)\
\-\ without\\:\\ 0\\.010702197693394469\ \(0\)\
\-\ a\\:\\ 0\\.010547867069643651\ \(0\)\
\-\ exam\\:\\ 0\\.009985286914625203\ \(0\)\
\-\ had\\:\\ 0\\.009807711804471852\ \(0\)\
\-\ 2\\:\\ 0\\.009787789875056097\ \(0\)\
\-\ findings\\:\\ 0\\.009674664552074254\ \(0\)\
\-\ to\\:\\ 0\\.009086555498786942\ \(0\)\
\-\ seen\\:\\ 0\\.008982061782274947\ \(0\)\
\-\ for\\:\\ 0\\.0077564696664118625\ \(0\)\
\-\ and\\:\\ 0\\.0076599576907326996\ \(0\)\
\-\ disease\\:\\ 0\\.007429455006466511\ \(0\)\
\-\ not\\:\\ 0\\.006568184424159231\ \(0\)\
\-\ history\\:\\ 0\\.006277736902697252\ \(0\)\
\-\ the\\:\\ 0\\.005882948285260672\ \(0\)\
\-\ or\\:\\ 0\\.005327248664700572\ \(0\)\
\-\ this\\:\\ 0\\.005112431985713473\ \(0\)\
\-\ old\\:\\ 0\\.0046539074301183755\ \(0\)\
\-\ \\(\\:\\ 0\\.003842349607680109\ \(0\)\
\-\ \\)\\:\\ 0\\.0037954132559218355\ \(0\)\
\-\ of\\:\\ 0\\.003718206408446439\ \(0\)\
\-\ is\\:\\ 0\\.0029909083956634343\ \(0\)\
\-\ with\\:\\ 0\\.0012447252775520184\ \(0\)\
\-\ \\.\\:\\ 0\\.001132963918000413\ \(0\)\
